SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-123856
Filing Date
2022-04-27
Accepted
2022-04-27 17:03:01
Documents
5
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d348353ddef14a.htm DEF 14A 373951
2 GRAPHIC g348353dsp001.jpg GRAPHIC 168919
3 GRAPHIC g348353dsp002.jpg GRAPHIC 84884
4 GRAPHIC g348353g35w82.jpg GRAPHIC 47236
5 GRAPHIC g348353g98t72.jpg GRAPHIC 63129
  Complete submission text file 0001193125-22-123856.txt   867908
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40551 | Film No.: 22860745
SIC: 2836 Biological Products, (No Diagnostic Substances)